BBP

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -1.28
Percentage change -2.04	%

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	4.97%	Total Holdings	58	Perf Week	2.56%
Sponsor	Virtus ETF Solutions	ETF Type		Tags	equity	Return% 3Y	12.36%	AUM	25.05M	Perf Month	0.70%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	5.28%	NAV/sh		Perf Quarter	16.06%
Index	LifeSci Biotechnology Products Index	Average Maturity		Tags	biotechnology	Return% 10Y		52W High	69.12 -11.37%	Perf Half Y	0.32%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	48.65 25.92%	Perf YTD	2.07%
Active/Passive		Quant Type		Tags	-	Flows% 1M	0.00%	Volatility	0.83% 1.08%	Perf Year	4.36%
Dividend TTM	-	ESG Type		Tags	-	Flows% 3M	12.59%	ATR (14)	1.06	Perf 3Y	43.59%
Dividend Ex-Date	Dec 20, 2017	Dividend Type		Sector/Theme		Flows% YTD	12.59%	RSI (14)	60.46	Perf 5Y	27.14%
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.56	Perf 10Y	74.50%
Expense	0.79%	Growth/Value		SMA20	3.08%	Flows% 3Y		Rel Volume	0.51	Prev Close	62.54
Inverse/Leveraged		Market Cap		SMA50	5.80%	Flows% 5Y		Avg Volume	3.32K	Price	61.26
IPO	Dec 17, 2014	Option/Short	Yes / Yes	SMA200	1.20%	Trades		Volume	1,695	Change	-2.04%

May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.80%
07:00AM	Loading…
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)

Virtus LifeSci Biotech Products ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

open in yahoo | open in marketwatch | open in google

Virtus LifeSci Biotech Products ETF

Upgrade your FINVIZ experience